ESR1 and triple-negative breast carcinoma: To determine the efficacy of a caffeine based chemotherapeutic strategy, we treated the triple-negative breast cancer cell line (MDA-MB-231), estrogen-receptor lacking breast cancer line (MCF7) and normal breast epithelial cell line (MCF10A) with a 125nM concentration of caffeine for one hour.